Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for cognitive function and negative symptoms in chronic schizophrenia
IRCT20250804066762N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of modafinil in schizophrenia, sponsored by Zahedan University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
modafinil
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20250804066762N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250804066762N1.